Rhythm Pharmaceuticals, Inc. (RYTM)
RYTM price $89.26 +0.64 +0.72%
- Ticker
- RYTM
- Price
- $89.26
- Change
- +0.64 +0.72%
- Market cap
- $6.15B
- P/E
- -28.50
- Forward P/E
- 34.22
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 61
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial products, dedicated to the discovery, development, and market launch of therapies addressing rare genetic conditions that cause obesity. Its leading pharmaceutical, IMCIVREE, functions as a powerful agonist of the melanocortin-4 receptor (MC4R). This medication is indicated for treating obesity stemming from deficiencies in…